Division of Product Quality Research (DPQR, HFD-940), Office of Testing and Research (OTR), Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Federal Research Center at White Oak, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA;
Process Assessment Branch Ⅱ, Division of Process Assessment 1 (DPA 1), Office of Process and Facilities (OPF), Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Federal Research Center at White Oak, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA;
Division of Biotechnology Review and Research Ⅱ (DBRRⅡ), Office of Biotechnology Products (OBP), Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Federal Research Center at White Oak, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA;
Division of Product Quality Research (DPQR, HFD-940), Office of Testing and Research (OTR), Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Federal Research Center at White Oak, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA;
Division of Biotechnology Review and Research Ⅱ (DBRRⅡ), Office of Biotechnology Products (OBP), Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Federal Research Center at White Oak, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA;
Division of Biotechnology Review and Research Ⅱ (DBRRⅡ), Office of Biotechnology Products (OBP), Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Federal Research Center at White Oak, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA;
Division of Product Quality Research (DPQR, HFD-940), Office of Testing and Research (OTR), Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Federal Research Center at White Oak, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA;
Division of Product Quality Research (DPQR, HFD-940), Office of Testing and Research (OTR), Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), Federal Research Center at White Oak, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA;
